First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics
about
First trimester serum tests for Down's syndrome screeningEarly prediction of preeclampsiaValidation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.Birth weight, breast cancer and the potential mediating hormonal environment.First Trimester Aneuploidy Screening Markers in Women with Pre-Gestational Diabetes Mellitus.Pregnancy Associated Plasma Protein-A and Placental Growth Factor in a Sub-Saharan African Population: A Nested Cross-Sectional Study.Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward SyndromeRapid and non invasive prenatal diagnosis.Risk factors and prediction of preeclampsia.Accuracy of self-reported smoking status in first trimester aneuploidy screening.First-trimester maternal factors and biomarker screening for preeclampsia.Screening for Down syndrome.The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Low first-trimester PAPP-A in IVF (fresh and frozen-thawed) pregnancies, likely due to a biological cause.Nuchal translucency measurement, free β-hCG and PAPP-A concentrations in IVF/ICSI pregnancies: systematic review and meta-analysis.First trimester combined screening - focus on early biochemistry.Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE).Allowing for ethnic group in antenatal screening for Down's syndrome.Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities.Effect of gestational age on first trimester maternal serum prenatal screening correction factors for ethnicity and IVF conception.Normative weight-adjusted models for the median levels of first trimester serum biomarkers for trisomy 21 screening in a specific ethnicity.First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation.Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history.Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history.Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center.Combined screening for preeclampsia and small for gestational age at 11-13 weeks.Maternal hemodynamics at 11-13 weeks of gestation and preterm birth.The fetal frontomaxillary facial angle in normal and trisomy 21 ultrasounds at 11-13(+6) weeks of gestation: findings among the ethnic Chinese compared with Caucasian.Evaluation of a two-step ultrasound examination protocol for the detection of major fetal structural defects.AlphaLISA for the determination of median levels of the free β subunit of human chorionic gonadotropin in the serum of pregnant women.First trimester maternal serum alpha-fetoprotein is not raised in pregnancies with open spina bifida.Reproducibility study of crown-rump length and biparietal diameter measurements in the first trimester.Correction of first trimester biochemical aneuploidy screening markers for smoking status: influence of gestational age, maternal ethnicity and cigarette dosage.QF-PCR rapid aneuploidy screen and aCGH analysis of cell free fetal (cff) DNA in supernatant of compromised amniotic fluids (AF).Maternal serum vitamin D at 11-13 weeks in pregnancies delivering small for gestational age neonates.Maternal serum adiponectin at 11-13 weeks of gestation in pregnancies delivering small for gestation neonates.Impact of a shift in nuchal translucency measurements on the detection rate of first-trimester Down syndrome screening: A population-based study.Placental volume at 11-13 weeks' gestation in the prediction of birth weight percentile.First-trimester ultrasound screening for trisomy 21 based on maternal age, fetal nuchal translucency, and different methods of ductus venosus assessment.
P2860
Q24187589-E86FC02A-BE30-4DC6-8ACD-270C3B90E64DQ34022344-2A9C561D-5FE7-4B32-A48A-B56CC373A35FQ34340985-0BBCB0E3-D9A5-4323-9651-4676980D22B3Q34344789-CC6B8777-4D33-438D-8EBE-46379ECC9800Q35667236-65C57F4C-275F-4685-90EB-F9EB0309110AQ36105745-01F5CFDD-8EF4-4EDE-A2BF-69675B787B7FQ36492863-D55BC8E9-C343-4D61-A777-6643B1EC652DQ36540807-AFF8C56E-428D-4C88-8B42-E98D6F2C818BQ37181558-902E002C-ED20-439C-8395-9DC7E21019BAQ37725865-E7D5CD61-EA54-4FC9-8BC8-75964EE8D835Q38077125-909E09E4-65F3-406E-9765-056495CB2309Q38207000-ADCFDE4E-4553-42DC-B405-D424E3E7CA64Q38235996-05221C6F-276A-4394-BAF7-77383B348E82Q38436237-8180BC3A-E433-4052-9043-4775A24C07CBQ38674432-343C17D4-73E6-4AF6-BBEF-1FF2C873E758Q38832165-73E07B4D-F86F-4680-BCE5-6FB0D244E800Q38893745-6C59824C-BEA1-4A9B-B97F-BA6F363A9EFEQ38906644-76FBE988-4102-486B-B7B3-3DB22241856FQ39027490-81DDA20D-C57E-4B8E-88CD-9D7776D1F4AAQ39431976-43BA5AA6-C8AE-484A-8335-9A09AFFEF168Q39516046-25578FB5-CDD7-429F-B5B6-34114D28C98DQ40096389-21A86A1A-54BF-4769-AE39-1A219171A1BBQ41499364-6240ED00-8563-4C18-8653-6BD8CA3B37C3Q41574187-F8859CB7-9703-4309-A8EB-58B98D85A5D8Q41593340-162780B3-8352-4467-A26C-9A1EC2EAE4FBQ43757389-AEFD0C6A-F7C2-4539-BF0F-734AD7344ECBQ43823700-994B01DF-F18A-4A9A-95E0-07BF6C7B148BQ43834094-5BB75A41-08CC-40DD-A19C-ED513EBA4116Q44272614-5287453F-E0AC-4CF8-A4F3-0D248E4CCAD5Q44494830-9289E83C-6596-457E-BA4B-AA9EE7D4C1ADQ44683641-FE40C8BE-7CF7-4255-95FC-287A4D333047Q45721469-5FDDD6F3-18ED-4AEA-9DC1-0888569996EEQ45742501-AAB1907A-F8AB-41C8-87B2-1D351C7347CFQ46321799-4D77A654-75BB-4C6C-8DCE-CE58A4810E21Q46624086-3838B8E9-5380-4166-A1B9-74C5FA8D4FE3Q46787073-8FAE5CAD-3931-421A-8369-868B2B407B64Q46941353-C9FD9A26-821C-4325-91C8-A37D2890D299Q47324714-F2A73DB8-6E4F-4E08-938F-81B5A7CBEA08Q47369964-EE2BA650-782C-4BB1-8627-6582FE39D92DQ47375200-ADB11BA0-F1EB-4FC3-9615-2A250852E6D3
P2860
First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics
description
article
@en
im Januar 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2008
@uk
name
First-trimester screening for ...... and pregnancy characteristics
@en
First-trimester screening for ...... and pregnancy characteristics
@nl
type
label
First-trimester screening for ...... and pregnancy characteristics
@en
First-trimester screening for ...... and pregnancy characteristics
@nl
prefLabel
First-trimester screening for ...... and pregnancy characteristics
@en
First-trimester screening for ...... and pregnancy characteristics
@nl
P2093
P356
P1476
First-trimester screening for ...... and pregnancy characteristics
@en
P2093
F. S. Molina
K. H. Nicolaides
K. O. Kagan
K. Spencer
P2860
P304
P356
10.1002/UOG.5332
P577
2008-01-01T00:00:00Z